Radha Ambalavanan

Ms. Radha Ambalavanan

Biomedical Researcher, The Self Research Institute, Broken Arrow, Oklahoma, USA
orcid
Registered Scientist (RSci) | Biomedical Researcher | Self R...

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2025 in Frontiers in Health Services
Verified
Journal Article
Open access
PDF file
Radha AmbalavananRadha Ambalavanan
Radha Ambalavanan
RSR Sterling Snead
R Sterling Snead
JMJulia Marczika
Julia Marczika
GTGideon Towett
Gideon Towett
AMAlex Malioukis
Alex Malioukis
MMMercy Mbogori-Kairichi
Mercy Mbogori-Kairichi
Background: Chronic conditions require robust healthcare data integration to support personalized care, real-time decision-making, and secure information exchange. However, fragmented data ecosystems disrupt interoperability, complicate patient-centered care (PCC), and present challenges for incorporating genomic data into clinical workflows.Objective: This systematic review with thematic synthesis aims to identify key challenges and synthesize existing strategies from the literature to inform the development of a foundational digital health data integration ecosystem.Methods: Following PRISMA guidelines, we systematically screened literature across multiple databases. A thematic synthesis approach was used to categorize findings into three primary themes: interoperability, PCC, and genomic data integration.Results: A total of 161 studies were included. Key challenges identified include semantic misalignment across commonly used healthcare standards such as HL7 FHIR and SNOMED CT, limited cross-system data exchange, inadequate patient engagement features in EHRs, and concerns regarding the security and clinical utility of genomic data. Strategies described across the literature include ontology-based interoperability models, AI-supported PCC frameworks, and blockchain-enabled genomic data governance.Conclusion: By analyzing current methodologies, research gaps, and implementation challenges, this review offers an evidence-based foundation to guide future advancements in healthcare data integration. It supports the development of scalable, privacy-preserving, and ethically governed data-sharing infrastructures that enable personalized medicine and real-time clinical interventions.Systematic Review Registration: https://osf.io/c2xvw.

29 August 2025 in Frontiers in Digital Health
Verified
Journal Article
Open access
PDF file
Radha AmbalavananRadha Ambalavanan
Radha Ambalavanan
RSR Sterling Snead
R Sterling Snead
JMJulia Marczika
Julia Marczika
GTGideon Towett
Gideon Towett
AMAlex Malioukis
Alex Malioukis
MMMercy Mbogori-Kairichi
Mercy Mbogori-Kairichi
Background: Ontologies serve as a foundational bridge between artificial intelligence (AI) and healthcare, enabling structured knowledge frameworks that enhance data interoperability, clinical decision support, and precision medicine.Objective: This perspective aims to highlight the essential role of ontologies in enabling adaptive, interoperable frameworks that evolve with technological and medical advances to support personalized, accurate, and globally connected healthcare solutions.Methods: This perspective is based on a targeted literature exploration conducted across PubMed, Scopus, and Google Scholar, prioritizing studies published between 2010 and 2025 and including earlier seminal works where necessary to provide historical context, focusing on ontology-driven AI applications in healthcare. Sources were selected for their relevance to semantic integration, interoperability, and interdisciplinary applicability.Results: Through the standardization of medical concepts, relationships, and terminologies, ontologies enable semantic integration across diverse healthcare datasets, including clinical, genomic, and phenotypic data. They also address challenges such as fragmented data and inconsistent terminologies. This semantic clarity supports AI applications in clinical decision support, predictive analytics, natural language processing (NLP), and patient-specific disease modeling.Conclusions: Despite their transformative potential, ontology integration faces significant challenges, including computational complexity, scalability, and semantic mismatches across evolving international standards, such as SNOMED CT and HL7 FHIR. Ethical concerns, particularly around data privacy, informed consent, and algorithmic bias, also require careful consideration. To address these challenges, this perspective outlines strategies including adaptive ontology models, robust governance frameworks, and AI-assisted ontology management techniques. Together, these approaches aim to support personalized, accurate, and globally interoperable healthcare systems.

13 December 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
AMAlex Malioukis
Alex Malioukis
RSR Sterling
R Sterling
JMJulia Marczika
Julia Marczika
Radha AmbalavananRadha Ambalavanan
Radha Ambalavanan
Although the impact of post-acute COVID-19 syndrome (PACS) on patients and public health is undeniably significant, its etiology remains largely unclear. Much research has been conducted on the pathophysiology, shedding light on various aspects; however, due to the multitude of symptoms and clinical conditions that directly or indirectly define PACS, it is challenging to establish definitive causations. In this exploration, through systematically reviewing the latest pathophysiological findings related to the neurological symptoms of the syndrome, we aim to examine how psychosocial and neuropsychological symptoms may overlap with neurological ones, and how they may not only serve as risk factors but also contribute to the persistence of some primary symptoms of the disorder. Findings from our synthesis suggest that psychological and psychosocial factors, such as anxiety, depression, and loneliness, may interact with neurological symptoms in a self-reinforcing feedback loop. This cycle seems to be affecting both physical and psychological distress, potentially increasing the persistence and severity of PACS symptoms. By pointing out this interaction, in this review study, we attempt to offer a new perspective on the interconnected nature of psychological, psychosocial, and neurological factors, emphasizing the importance of integrated treatment approaches to disrupt this cycle and improve outcomes when possible.

Radha AmbalavananRadha Ambalavanan
Radha Ambalavanan
RSR Sterling
R Sterling
JMJulia Marczika
Julia Marczika
KKKarina Kozinsky
Karina Kozinsky
EAEdris Aman
Edris Aman
The ongoing COVID-19 pandemic has profoundly affected millions of lives globally, with some individuals experiencing persistent symptoms even after recovering. Understanding and managing the long-term sequelae of COVID-19 is crucial for research, prevention, and control. To effectively monitor the health of those affected, maintaining up-to-date health records is essential, and digital health informatics apps for surveillance play a pivotal role. In this review, we overview the existing literature on identifying and characterizing long COVID manifestations through hierarchical classification based on Human Phenotype Ontology (HPO). We outline the aspects of the National COVID Cohort Collaborative (N3C) and Researching COVID to Enhance Recovery (RECOVER) initiative in artificial intelligence (AI) to identify long COVID. Through knowledge exploration, we present a concept map of clinical pathways for long COVID, which offers insights into the data required and explores innovative frameworks for health informatics apps for tackling the long-term effects of COVID-19. This study achieves two main objectives by comprehensively reviewing long COVID identification and characterization techniques, making it the first paper to explore incorporating long COVID as a variable risk factor within a digital health informatics application. By achieving these objectives, it provides valuable insights on long COVID’s challenges and impact on public health.

1 May 2025 in Digital Health
Verified
Journal Article
Open access
GTGideon Towett
Gideon Towett
RSR Sterling
R Sterling
JMJulia Marczika
Julia Marczika
Radha AmbalavananRadha Ambalavanan
Radha Ambalavanan
MKMercy Mbogori Kairichi
Mercy Mbogori Kairichi
AMAlex Malioukis
Alex Malioukis
The growing prevalence of chronic diseases such as diabetes, cardiovascular diseases (CVDs), and hypertension calls for innovative strategies for disease surveillance and management. Digital health technologies (DHTs) offer a transformative approach to chronic disease management through real-time, personalized health monitoring and enhanced patient engagement; however, they also present inherent limitations. This narrative review synthesizes current applications of DHTs in the management of diabetes, CVDs, and hypertension, with a focus on advancements in artificial intelligence, digital therapeutics, and remote patient monitoring. A framework of solutions is proposed, comprising six key pillars: (1) data accuracy and standardization through artificial intelligence–enhanced calibration and multisensor fusion; (2) user engagement and compliance supported by gamification and behavioral science; (3) interoperability and clinical integration through Fast Healthcare Interoperability Resources and Health Level Seven standards; (4) accessibility and cost barriers addressed through frugal innovation, open-source platforms, reimbursement policies, and user education; (5) privacy and ethics, employing blockchain and federated learning for secure data governance; and (6) regulatory and policy considerations, advocating for global harmonization and supportive reimbursement models. This framework aims to enhance the reliability, accessibility, and effectiveness of DHTs in chronic disease management. The review provides actionable insights for stakeholders, including developers, healthcare professionals, and policymakers, on optimizing the design, implementation, and regulation of DHTs, ultimately improving chronic disease outcomes.

10 February 2026 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
AMAlex Malioukis
Alex Malioukis
RSR Sterling Snead
R Sterling Snead
JMJulia Marczika
Julia Marczika
Radha AmbalavananRadha Ambalavanan
Radha Ambalavanan
GTGideon Towett
Gideon Towett
MMMercy Mbogori-Kairichi
Mercy Mbogori-Kairichi
Introduction: Agitation is a common and burdensome symptom in people with dementia, particularly when compounded by impaired communication, making early detection and effective management difficult. Wearable sensor technologies may offer a promising avenue for supporting real-time behavioral monitoring and personalized care in this context. Objective: This study aims to examine the current clinical and technological capabilities of wearable sensor systems for detecting and managing agitation in persons with dementia, to assess whether these technologies can effectively support personalized care. Additionally, it seeks to identify key challenges and opportunities in applying human-centered design principles and tailored interventions to improve outcomes for both patients and caregivers. Methods: We conducted a scoping literature review, registered on OSF 1 and guided by PRISMA-ScR guidelines. Five databases—Google Scholar, Scopus, PubMed, PsycINFO, and ACM Digital Library—were searched for English-language peer-reviewed studies published between 2016 and early 2025. From an initial pool of 798 articles, a multi-phase screening process led to a final inclusion of 13 studies that met predefined criteria. Results: The reviewed studies demonstrated that wearable sensors, particularly those employing multimodal data and personalized machine learning models, enable reliable detection of agitation symptoms and support timely, tailored interventions. The concept of digital phenotyping emerged as a promising approach for capturing complex behavioral signatures, while user-centered design was identified as essential for adoption and long-term compliance. Discussion: The evidence identified in this scoping review indicates that wearable and multimodal sensor technologies may offer promising approaches for monitoring agitation in dementia, while acknowledging that the research remains in early stages. We recommend future research focus on large-scale, longitudinal validation and the expansion of these tools to other populations with communication challenges, such as individuals with autism spectrum disorder or traumatic brain injury. Systematic review registration: https://doi.org/10.17605/OSF.IO/DNHYM .